Caxton Associates (UK)’s Opko Health OPK Stock Holding History

Caxton Associates (UK)’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-78,128	Closed	-$130K	–	847
2025 Q1	$130K	Buy	+78,128	New	+$129K	﹤0.01%	731

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Caxton Associates (UK)'s OPK Position: Q2 2025 in Review

Caxton Associates (UK) sold out of Opko Health (OPK) in Q2 2025, closing a stake of 78,128 shares — an estimated $130K sold.

Caxton Associates (UK) first reported a position in OPK in Q1 2025 and held it in 1 quarter. The position peaked at $130K in Q1 2025. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2025.

Caxton Associates (UK) reported no remaining Opko Health position as of Q2 2025 after selling out during the quarter.
Caxton Associates (UK) sold 78,128 Opko Health shares in Q2 2025, an estimated $130K.
Caxton Associates (UK) first reported a position in Opko Health in Q1 2025 and held it in 1 quarter.
Caxton Associates (UK)'s Opko Health position peaked at $130K in Q1 2025.
222 funds tracked by Wall St. Rank held Opko Health as of Q2 2025.

Based on Caxton Associates (UK)'s 13F filing for Q2 2025, filed 15 Aug 2025.